PCN88 AN ECONOMIC EVALUATION OF RITUXIMAB VERSUS OTHER FIRST-LINE TREATMENTS FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN POLAND
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74339-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)74339-4/fulltext
Title :
PCN88 AN ECONOMIC EVALUATION OF RITUXIMAB VERSUS OTHER FIRST-LINE TREATMENTS FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN POLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74339-4&doi=10.1016/S1098-3015(10)74339-4
First page :
Section Title :
Open access? :
No
Section Order :
263